Intraocular pressure reduction after repeated selective laser trabeculoplasty (SLT): A prospective randomised clinical trial

St Eriks Eye Hospital (Sweden)0 个研究点目标入组 40 人开始时间: 2010年3月16日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients suffering from glaucoma or Ocular Hypertenstion (OHT)
•1.1. Primary open angle glaucoma (POAG) - open angle defined as > grade II (Shaffer classification: scale 0-IV) assessed by gonioscopy
•1.2. Pigmentary and pseudoexfoliative glaucoma
•1.3. OHT to be treated with SLT 2 both with and without eye-drops.
•2. If both eyes must be treated just one will be selected at random.
•3. Older than 18 years, no upper age limit
•4. Men and women

•1. Patients treated with cortisone or immunosuppressive drugs
•2. Patients suffering from ocular or systemic inflammatory diseases
•3. Patients with Possner-Schlossman syndrome
•4. Patients that cannot be treated with SLT due to eye?s characteristics (shallow anterior chamber) or bad collaboration

发起方

St Eriks Eye Hospital (Sweden)